-
EP1406897
European procedure
Extract from the Register of European Patents
EP About this file: EP1406897
| EP1406897 - COMPOUNDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 18.01.2008 Database last updated on 22.08.2024 | Most recent event Tooltip | 11.09.2009 | Lapse of the patent in a contracting state New state(s): TR | published on 14.10.2009 [2009/42] | Applicant(s) | For all designated states SMITHKLINE BEECHAM PLC 980 Great West Road Brentford Middlesex TW8 9GS / GB | [2007/11] |
| Former [2004/16] | For all designated states SmithKline Beecham plc 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Inventor(s) | 01 /
CHAN, Wai Ngor GlaxoSmithKline New Frontiers Science Park South Third Avenue Harlow Essex, CM19 5AW / GB | 02 /
JOHNS, Amanda GlaxoSmithKline New Frontiers Science Park South Third Avenue Harlow Essex CM19 5AW / GB | 03 /
JOHNSON, Christopher Norbert GlaxoSmithKline New Frontiers Science Park South Third Avenue Harlow Essex CM19 5AW / GB | 04 /
NOVELLI, Riccardo GlaxoSmithKline New Frontiers Science Park South Third Avenue Harlow Essex CM19 5AW / GB | 05 /
PORTER, Roderick Alan GlaxoSmithKline New Frontiers Science Park South Third Avenue Harlow Essex CM19 5AW / GB | [2007/11] |
| Former [2004/16] | 01 /
CHAN, Wai Ngor GlaxoSmithKline New Frontiers Scie nce Park South Third Avenue Harlow Essex, CM19 5AW / GB | ||
| 02 /
JOHNS, Amanda GlaxoSmithKline New Frontiers Science Park South Third Avenue Harlow Essex CM19 5AW / GB | |||
| 03 /
JOHNSON, Christopher Norbert GlaxoSmithKline New Frontiers Science Park South Third Avenue Harlow ESsex CM19 5AW / GB | |||
| 04 /
NOVELLI, Riccardo GlaxoSmithKline New Frontiers Science Park South Third Avenue Harlow Essex CM19 5AW / GB | |||
| 05 /
PORTER, Roderick Alan GlaxoSmithKline New Frontiers Science Park South Third Avenue Harlow Essex CM19 5AW / GB | Representative(s) | Lawrence, Geoffrey Mark Prouse GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
| Former [2004/16] | Lawrence, Geoffrey Mark Prouse GlaxoSmithKline, Corporate Intellectual Property, 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 02780910.2 | 25.06.2002 | [2004/16] | WO2002EP07007 | Priority number, date | GB20010015862 | 28.06.2001 Original published format: GB 0115862 | GB20010030347 | 19.12.2001 Original published format: GB 0130347 | [2004/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO03002559 | Date: | 09.01.2003 | Language: | EN | [2003/02] | Type: | A2 Application without search report | No.: | EP1406897 | Date: | 14.04.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.01.2003 takes the place of the publication of the European patent application. | [2004/16] | Type: | B1 Patent specification | No.: | EP1406897 | Date: | 14.03.2007 | Language: | EN | [2007/11] | Search report(s) | International search report - published on: | EP | 28.08.2003 | Classification | IPC: | C07D413/14, C07D413/06, C07D417/14, C07D401/14, C07D471/04, C07D417/04, A61P25/00, A61K31/4545 | [2004/16] | CPC: |
C07D413/14 (EP,US);
A61P11/00 (EP);
A61P15/10 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/04 (EP);
A61P25/06 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
A61P5/10 (EP);
A61P5/12 (EP);
A61P9/00 (EP);
C07D401/14 (EP,US);
C07D413/06 (EP,US);
C07D417/04 (EP,US);
C07D417/14 (EP,US);
C07D471/04 (EP,US)
(-)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/16] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | VERBINDUNGEN | [2004/16] | English: | COMPOUNDS | [2004/16] | French: | COMPOSES | [2004/16] | Entry into regional phase | 29.12.2003 | National basic fee paid | 29.12.2003 | Designation fee(s) paid | 29.12.2003 | Examination fee paid | Examination procedure | 22.01.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 29.12.2003 | Examination requested [2004/16] | 17.10.2005 | Despatch of a communication from the examining division (Time limit: M06) | 12.04.2006 | Reply to a communication from the examining division | 13.10.2006 | Communication of intention to grant the patent | 17.01.2007 | Fee for grant paid | 17.01.2007 | Fee for publishing/printing paid | Opposition(s) | 17.12.2007 | No opposition filed within time limit [2008/08] | Fees paid | Renewal fee | 04.06.2004 | Renewal fee patent year 03 | 06.06.2005 | Renewal fee patent year 04 | 27.03.2006 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 14.03.2007 | CH | 14.03.2007 | CY | 14.03.2007 | DK | 14.03.2007 | FI | 14.03.2007 | LI | 14.03.2007 | NL | 14.03.2007 | TR | 14.03.2007 | SE | 14.06.2007 | GR | 15.06.2007 | IE | 25.06.2007 | LU | 25.06.2007 | MC | 30.06.2007 | PT | 14.08.2007 | [2009/42] |
| Former [2009/38] | AT | 14.03.2007 | |
| CH | 14.03.2007 | ||
| CY | 14.03.2007 | ||
| DK | 14.03.2007 | ||
| FI | 14.03.2007 | ||
| LI | 14.03.2007 | ||
| NL | 14.03.2007 | ||
| SE | 14.06.2007 | ||
| GR | 15.06.2007 | ||
| IE | 25.06.2007 | ||
| LU | 25.06.2007 | ||
| MC | 30.06.2007 | ||
| PT | 14.08.2007 | ||
| Former [2009/34] | AT | 14.03.2007 | |
| CH | 14.03.2007 | ||
| CY | 14.03.2007 | ||
| DK | 14.03.2007 | ||
| FI | 14.03.2007 | ||
| LI | 14.03.2007 | ||
| NL | 14.03.2007 | ||
| SE | 14.06.2007 | ||
| GR | 15.06.2007 | ||
| IE | 25.06.2007 | ||
| MC | 30.06.2007 | ||
| PT | 14.08.2007 | ||
| Former [2008/25] | AT | 14.03.2007 | |
| CH | 14.03.2007 | ||
| DK | 14.03.2007 | ||
| FI | 14.03.2007 | ||
| LI | 14.03.2007 | ||
| NL | 14.03.2007 | ||
| SE | 14.06.2007 | ||
| GR | 15.06.2007 | ||
| IE | 25.06.2007 | ||
| MC | 30.06.2007 | ||
| PT | 14.08.2007 | ||
| Former [2008/22] | AT | 14.03.2007 | |
| CH | 14.03.2007 | ||
| DK | 14.03.2007 | ||
| FI | 14.03.2007 | ||
| LI | 14.03.2007 | ||
| NL | 14.03.2007 | ||
| SE | 14.06.2007 | ||
| GR | 15.06.2007 | ||
| MC | 30.06.2007 | ||
| PT | 14.08.2007 | ||
| Former [2008/09] | AT | 14.03.2007 | |
| CH | 14.03.2007 | ||
| DK | 14.03.2007 | ||
| FI | 14.03.2007 | ||
| LI | 14.03.2007 | ||
| NL | 14.03.2007 | ||
| SE | 14.06.2007 | ||
| MC | 30.06.2007 | ||
| PT | 14.08.2007 | ||
| Former [2008/08] | AT | 14.03.2007 | |
| CH | 14.03.2007 | ||
| DK | 14.03.2007 | ||
| FI | 14.03.2007 | ||
| LI | 14.03.2007 | ||
| NL | 14.03.2007 | ||
| SE | 14.06.2007 | ||
| PT | 14.08.2007 | ||
| Former [2007/49] | AT | 14.03.2007 | |
| CH | 14.03.2007 | ||
| FI | 14.03.2007 | ||
| LI | 14.03.2007 | ||
| NL | 14.03.2007 | ||
| SE | 14.06.2007 | ||
| PT | 14.08.2007 | ||
| Former [2007/46] | AT | 14.03.2007 | |
| CH | 14.03.2007 | ||
| FI | 14.03.2007 | ||
| LI | 14.03.2007 | ||
| NL | 14.03.2007 | ||
| SE | 14.06.2007 | ||
| Former [2007/39] | CH | 14.03.2007 | |
| FI | 14.03.2007 | ||
| LI | 14.03.2007 | ||
| NL | 14.03.2007 | ||
| SE | 14.06.2007 | Cited in | International search | [A]US5547978 (CHRISTENSEN BURTON G [US], et al) [A] 1,9 * column 1; examples 1,3 *; | [DA]WO9958533 (SMITHKLINE BEECHAM PLC [GB], et al) [DA] 1,9* claims 1,10 *; | [A]WO0037458 (SCHERING CORP [US]) [A] 1,9 * examples 20-23; claim 22 *; | [X] - MARSHALL, KENT S. ET AL, "Absolute configuration of.alpha.-methyldopamine formed metabolically from.alpha.-methyldopa in man", JOURNAL OF MEDICINAL CHEMISTRY (1973), 16(3), 266-70, XP002234454 [X] 1 * example 6 * DOI: http://dx.doi.org/10.1021/jm00261a023 |